Alltrna
Latest round
- Series B
Last raised
- Aug 2023
Total raised
- $134M
Investors
- 1
About Alltrna
Founded in 2018 and headquartered in Cambridge, US, Alltrna, Inc. focuses on utilizing engineered transfer RNA (tRNA) technology to address genetic conditions linked to nonsense mutations.Alltrna specializes in developing universal tRNA medicines designed to restore disrupted protein production across a wide range of genetic diseases linked by shared underlying genetic mutations. Their core technology involves engineered tRNA molecules that can correct nonsense mutations, allowing for the delivery of necessary amino acids that produce full-length proteins essential for cellular function.Alltrna generates revenue through partnerships with research institutions and pharmaceutical companies focused on genetic therapies. The company is strategically focused on developing new products aimed at treating genetic conditions caused by PTCs, with ambitions to penetrate additional global markets where genetic disorders are prevalent.
Who invested in Alltrna
1 investor across 2 rounds
See all investors in Alltrna
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alltrna
Who invested in Alltrna?
Alltrna has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alltrna raised?
Alltrna has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alltrna last raise money?
Alltrna's most recent round on record is a Series B, in Aug 2023.
What does Alltrna do?
Founded in 2018 and headquartered in Cambridge, US, Alltrna, Inc.
Where is Alltrna headquartered?
Alltrna is headquartered in Cambridge, US.
Which VCs invest in companies like Alltrna?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alltrna's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Alltrna? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.